iBionext
Est. dry powder
—
Not reported
AUM
—
Not reported
Latest fund
$112.1M
iBionext Growth Fund
Est. cheque size
$1.7M–
From fund sizes
Deals, last 12 months
—
Not reported
About iBionext
iBionext is a France-based venture capital and venture studio firm, specializing in the creation, development, and financing of innovative healthcare and deep technology companies. The firm focuses on opportunities in biotechnology, medtech, digital health, and related technologies across France and international markets.
- Type
- Venture Capital Firm
- Headquarters
- Paris, France
- Stages
- SeedSeries ASeries BSeries C
- Est. cheque size
- $1.7M–$14.2M
- Sectors
- Healthcare
- Regions
- Europe
- Strategies
- Pre-Seed, Seed, Series A
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- Series B6
- Series C3
- Series A2
Across 17 deals
Portfolio sectors
- Software2
- Biotechnology1
- Consumer Products1
- Healthcare IT1
- Semiconductors1
Across 6 companies
Portfolio countries
- France5
- US1
Across 6 companies
Recent investments
Newest 5 of 17
- Series B$38.6M
BrainEver SAS
Jul 2025 · Series B
- Unspecified Round$10.5M
Tilak Healthcare
Oct 2023 · Unspecified Round
- Series C$19.4M
Prophesee SA
Sep 2022 · Series C
- Series C$50.8M
Chronocam SAS
Sep 2021 · Series C
- Unspecified Round$7.3M
Tilak Healthcare
Aug 2021 · Unspecified Round
Offices
1 location
- Paris, FranceHQ
Questions about iBionext
How much does iBionext invest per deal?
Based on the size of its funds, iBionext writes estimated cheques of $1.7M–$14.2M. Lead cheques usually sit at the top of that range and follow-on cheques lower.
What stages does iBionext invest in?
iBionext has invested at Seed, Series A, Series B and Series C. Its most frequent rounds on record are Series B, Series C and Series A.
What has iBionext invested in recently?
Recent investments include BrainEver SAS, Tilak Healthcare and Prophesee SA.